These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 10459536

  • 1. CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation.
    Bruno B, Nash RA, Wallace PM, Gass MJ, Thompson J, Storb R, McSweeney PA.
    Transplantation; 1999 Aug 15; 68(3):338-44. PubMed ID: 10459536
    [Abstract] [Full Text] [Related]

  • 2. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS, Mathes DW, Georges GE, Kuhr CS, Chang J, Butts TM, Storb R.
    Transplantation; 2012 Sep 27; 94(6):562-8. PubMed ID: 22929594
    [Abstract] [Full Text] [Related]

  • 3. The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation.
    Barsoukov AA, Moore PF, Storb R, Santos EB, Sandmaier BM.
    Transplantation; 1999 May 27; 67(10):1329-35. PubMed ID: 10360586
    [Abstract] [Full Text] [Related]

  • 4. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
    Lange S, Steder A, Glass Ä, Killian D, Wittmann S, Machka C, Werner J, Schäfer S, Roolf C, Junghanss C.
    Biol Blood Marrow Transplant; 2016 Apr 27; 22(4):637-643. PubMed ID: 26802322
    [Abstract] [Full Text] [Related]

  • 5. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
    Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem HP, Leisenring W, Shulman H.
    Blood; 1997 Apr 15; 89(8):3048-54. PubMed ID: 9108426
    [Abstract] [Full Text] [Related]

  • 6. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
    Storb R, Yu C, Zaucha JM, Deeg HJ, Georges G, Kiem HP, Nash RA, McSweeney PA, Wagner JL.
    Blood; 1999 Oct 01; 94(7):2523-9. PubMed ID: 10498626
    [Abstract] [Full Text] [Related]

  • 7. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J, Urbano-Ispizua A, Lawler M, Rozman C, Gardiner N, Marín P, Salgado C, Féliz P, McCann S, Montserrat E.
    Exp Hematol; 1998 May 01; 26(5):415-20. PubMed ID: 9590658
    [Abstract] [Full Text] [Related]

  • 8. Purified canine CD34+Lin- marrow cells transduced with retroviral vectors give rise to long-term multi-lineage hematopoiesis.
    Bruno B, Goerner MA, Nash RA, Storb R, Kiem HP, McSweeney PA.
    Biol Blood Marrow Transplant; 2001 May 01; 7(10):543-51. PubMed ID: 11760086
    [Abstract] [Full Text] [Related]

  • 9. Characterization of monoclonal antibodies that recognize canine CD34.
    McSweeney PA, Rouleau KA, Wallace PM, Bruno B, Andrews RG, Krizanac-Bengez L, Sandmaier BM, Storb R, Wayner E, Nash RA.
    Blood; 1998 Mar 15; 91(6):1977-86. PubMed ID: 9490680
    [Abstract] [Full Text] [Related]

  • 10. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.
    Zaucha JM, Zellmer E, Georges G, Little MT, Storb R, Storer B, Torok-Storb B.
    Biol Blood Marrow Transplant; 2001 Mar 15; 7(11):613-9. PubMed ID: 11760149
    [Abstract] [Full Text] [Related]

  • 11. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
    Fukuda T, Kerbauy FR, Gooley T, Santos EB, Storb R, Sandmaier BM.
    Transplantation; 2006 Aug 15; 82(3):332-9. PubMed ID: 16906030
    [Abstract] [Full Text] [Related]

  • 12. Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
    Mattsson J, Uzunel M, Remberger M, Tammik L, Omazic B, Levitsky V, Zou JZ, Hentschke P, Ringdén O.
    Clin Exp Immunol; 2001 Jan 15; 123(1):162-9. PubMed ID: 11168014
    [Abstract] [Full Text] [Related]

  • 13. Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
    Ringdén O, Söderdahl G, Mattsson J, Uzunel M, Remberger M, Hentschke P, Hägglund H, Sparrelid E, Elmhorn-Rosenborg A, Duraj F, Zetterquist H, Ericzon BG.
    Transplantation; 2000 May 27; 69(10):2043-8. PubMed ID: 10852594
    [Abstract] [Full Text] [Related]

  • 14. Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors.
    Yabe H, Yabe M, Hattori K, Hinohara T, Morimoto T, Nakamura Y, Noma M, Takei M, Kobayashi N, Tsuji K, Kato S.
    Bone Marrow Transplant; 1996 Jun 27; 17(6):985-91. PubMed ID: 8807104
    [Abstract] [Full Text] [Related]

  • 15. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Jun 27; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 16. Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation.
    Zaucha JA, Yu C, Lothrop CD, Nash RA, Sale G, Georges G, Kiem HP, Niemeyer GP, Dufresne M, Cao Q, Storb R.
    Biol Blood Marrow Transplant; 2001 Jun 27; 7(1):14-24. PubMed ID: 11215693
    [Abstract] [Full Text] [Related]

  • 17. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.
    Burroughs L, Mielcarek M, Little MT, Bridger G, Macfarland R, Fricker S, Labrecque J, Sandmaier BM, Storb R.
    Blood; 2005 Dec 01; 106(12):4002-8. PubMed ID: 16105977
    [Abstract] [Full Text] [Related]

  • 18. Isolation and characterization of canine hematopoietic progenitor cells.
    Niemeyer GP, Hudson J, Bridgman R, Spano J, Nash RA, Lothrop CD.
    Exp Hematol; 2001 Jun 01; 29(6):686-93. PubMed ID: 11378263
    [Abstract] [Full Text] [Related]

  • 19. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
    Takatu A, Nash RA, Zaucha JM, Little MT, Georges GE, Sale GE, Zellmer E, Kuhr CS, Lothrop CD, Storb R.
    Biol Blood Marrow Transplant; 2003 Nov 01; 9(11):674-82. PubMed ID: 14652850
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J, Brugger W, Bertz H, Behringer D, Kunzmann R, Weber-Nordt RM, Kanz L, Mertelsmann R.
    Bone Marrow Transplant; 1996 Dec 01; 18(6):1081-6. PubMed ID: 8971376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.